Long-Term Acute Care Hospital Denial Escalation
A post-acute analysis for LTACH admission, transfer, or extended-stay denials. It organizes prolonged acute medical needs, organ support, respiratory or wound complexity, frequent physician management, treatment intensity, instability, and why a lower setting could not safely or effectively provide the documented care.
A bounded clinical support service.
A post-acute analysis for LTACH admission, transfer, or extended-stay denials. It organizes prolonged acute medical needs, organ support, respiratory or wound complexity, frequent physician management, treatment intensity, instability, and why a lower setting could not safely or effectively provide the documented care.
Scope boundary. The client retains filing, portal work, deadlines, signatures, coding, legal strategy, patient care, and any required U.S.-licensed or specialty opinion unless a separate approved scope expressly says otherwise.
The decision problem this service addresses.
LTACH decisions can turn on whether the patient still needs hospital-level care rather than on diagnosis alone. HHS-OIG reported in June 2026 that Medicare Advantage organizations collectively overturned 36% of appealed LTACH denials in the reviewed period, with significant variation across organizations and contractors. That supports targeted review, not an assumption that every denial is appealable. (HHS-OIG, 2026)
What the review must resolve.
Ongoing acute need
Which active problems still require hospital-level intervention or surveillance?
Treatment intensity
What respiratory, wound, infectious, nutritional, renal, cardiac, or other interventions are being delivered?
Physician management
What decisions and adjustments require frequent hospital physician oversight?
Lower-setting capability
Could SNF, IRF, or home safely provide the actual plan?
Trajectory
Is the patient improving toward transition, unstable, or repeatedly escalating?
Time period
Which exact days remain supported as intensity changes?
The clinical work product.
- Chronology of persistent acute needs and interventions.
- Evidence map to the applicable admission/continued-stay pathway.
- Comparison with the realistic lower-level alternative.
- Direct rebuttal, adverse evidence, missing-document list, risk rating, and writer handoff.
What the client must supply.
Turnaround begins after the agreed record is complete and usable. New records, a different denial rationale, another review period, or a second independent issue can change scope.
- LTACH denial notice, dates, and exact rationale
- Referring-hospital and LTACH physician, nursing, respiratory, wound, therapy, pharmacy, nutrition, and discharge records
- Payer policy or authorized criteria
- Proposed alternative level and documented capability
- Prior reviews, authorized days, and changes across the disputed interval
How buyers handle the work today.
- LTACH internal case management and physician leadership.
- Referring-hospital utilization management.
- Physician-advisory and post-acute denial vendors.
- Payer-specific criteria software and licensed external review.
- Treating specialists who can document ongoing acute need.
The intended role in the workflow.
The service is a focused clinical record analysis rather than facility-wide authorization outsourcing. Its higher price relative to SNF reflects the expected record length and medical complexity, not an assumption about reimbursement value.
What the service is designed to prevent.
These are not proof that a denial is wrong. They are ways a potentially supportable case becomes unfocused, overstated, or routed to the wrong capability.
- Using chronic complexity as a substitute for current hospital-level treatment
- Failing to identify the exact days supported
- Calling a lower setting unsafe without showing what care it cannot deliver
- Ignoring a documented weaning or transition milestone
- Combining weeks of materially different intensity into one argument
Market comparison and current Clinovian scope.
No public like-for-like per-case rate was identified. Enterprise vendors and physician advisors generally quote privately. Claim-value ranges on the current Clinovian site should not be treated as market facts unless tied to a client’s actual contract and claim.
Clinovian scope and pricing: Quote required under the current combined post-acute pricing. Normal public turnaround: 5–7 business days after complete usable inputs.
Final scope, fixed fee, and turnaround are confirmed before records are transferred; the Engagements & Pricing page remains the public pricing framework.
When to choose it—and when not to.
Choose it for a selected clinical dispute where a disciplined setting comparison is missing. Do not choose it for certification, coding, portal filing, or when the record does not document the acute interventions the argument would require.
Send the decision, not the whole account. Fit is confirmed before records.
Provide the denial or request type, payer or plan, review stage, record size, and client-controlled deadline. No PHI is required for the initial scope review.